Jefferies Financial Group Inc. Exact Sciences Corp Call Options Transaction History

Jefferies Financial Group Inc.

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 13, 2024	SELL	$56.27 - $73.77 $12.1 Million - $15.8 Million	-214,700 Reduced 92.46%	17,500 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $6.24 Million - $8 Million	105,700 Added 83.56%	232,200 $17.2 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $1.44 Million - $2.16 Million	21,800 Added 20.82%	126,500 $8.63 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $2.88 Million - $4.36 Million	45,900 Added 78.06%	104,700 $9.83 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $2.59 Million - $3.88 Million	-54,800 Reduced 48.24%	58,800 $3.99 Million
Q4 2022 Sep 21, 2023	BUY	$30.35 - $53.15 $270,115 - $473,035	8,900 Added 8.5%	113,600 $5.62 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $3.45 Million - $6.04 Million	113,600 New	113,600 $5.62 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.93B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Jefferies Financial Group Inc. with notifications on news.